Becton, Dickinson and Co. (BDX) Valuation
Historical valuation analysis based on 1281 data points (2021-09-10 to 2026-10-16)
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention produc...
Becton, Dickinson and Co. (BDX) currently trades at a P/E ratio of 55.45 (historical range: 32.19–81.94, median: 45.15), placing it at the 81th percentile — expensive relative to its history, P/S ratio of 2.60 (range: 1.88–7.15, 15th percentile — cheap relative to its history), EV/EBITDA of 35.55 (range: 19.29–72.05, 33th percentile).
Becton, Dickinson and Co. trades below its historical valuation range, with most metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 55.45 | 45.15 | 81th | expensive relative to its history |
| P/S Ratio | 2.60 | 3.85 | 15th | cheap relative to its history |
| EV/EBITDA | 35.55 | 38.79 | 33th | below its historical average |
| FCF Yield | 5.23% | 3.53% | 91th | cheap relative to its history |
Becton, Dickinson and Co. (BDX) Valuation & P/E History
Becton, Dickinson and Co. (BDX) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry currently trading at $191.75 with a market capitalization of $52.2 billion. This page provides historical valuation analysis for BDX based on 1281 data points covering 2021-09-10 to 2026-10-16. The P/E ratio of 55.45 is above the historical median of 45.15, placing BDX at the 81th percentile of its valuation range. The P/S ratio of 2.60 compares to a median of 3.85.
BDX Valuation Metrics & Historical Range
The valuation table above shows Becton, Dickinson and Co.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether BDX is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests BDX is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Becton, Dickinson and Co..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is BDX Overvalued or Undervalued?
Becton, Dickinson and Co. trades below its historical valuation range, with most metrics below their median levels. The overall valuation percentile of 43 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive BDX is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full BDX analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.BDX trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.